Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways

Therapeutic Advances in Cardiovascular Disease

Volumn 5, Issue 2, 2011, Pages 99-111

  Lou, Lixia ^a   Zhang, Dongmei ^a   Wu, Aiming ^a   Zhao, Mingjing ^a   Wang, Shuoren ^a   Pan, Chunshui ^b   Huo, Yingqing ^b   Chen, Meng ^b   Singh, Gurbakhshish ^c   Li, Jian ^c  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b PEKING UNIVERSITY   (China)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

CAT; L arginine; Myocardial infarction; Sal B; Tan IIA

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 MORPHOLINO 8 PHENYLCHROMONE; AMINO ACID TRANSPORTER; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN KINASE B; SALVIANOLIC ACID B; TANSHINONE IIA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; ECHOCARDIOGRAPHY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; GENE AMPLIFICATION; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART INJURY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HUMAN; HUMAN CELL; HUMAN TISSUE; LEFT VENTRICULAR FRACTIONAL SHORTENING; MALE; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVIA MILTIORRHIZA; SCINTILLATION COUNTING; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; WESTERN BLOTTING;

AMINO ACID TRANSPORT SYSTEMS, BASIC; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANIMALS; ARGININE; BENZOFURANS; CARDIOVASCULAR AGENTS; CATIONIC AMINO ACID TRANSPORTER 1; CELLS, CULTURED; CHROMONES; DISEASE MODELS, ANIMAL; DITERPENES, ABIETANE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOLINES; MYOCARDIAL INFARCTION; MYOCARDIUM; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS; VASODILATION;

EID: 79956024633     PISSN: 17539447     EISSN: 17539455     Source Type: Journal    
DOI: 10.1177/1753944710396538     Document Type: Article

References (26)

1. Baudin B. Bruneel A. Bosselut N. Vaubourdolle M. (2007) A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2: 481–485.
2. Charan Sahoo K. Arora S. Goyal S. Kishore K. Ray R. Chandra Nag T. et al (2009) Cardioprotective effects of benazepril, an angiotensin-converting enzyme inhibitor, in an ischaemia-reperfusion model of myocardial infarction in rats. J Renin Angiotensin Aldosterone Syst 10: 201–209.
3. Chen Y. Ruan Y. Li L. Chu Y. Xu X. Wang Q. et al (2003) Effects of Salvia miltiorrhiza extracts on rat hypoxic pulmonary hypertension, heme oxygenase-1 and nitric oxide synthase. Chin Med J (Engl) 116: 757–760.
4. Closs E.I. Simon A. Vekony N. Rotmann A. (2004) Plasma membrane transporters for arginine. J Nutr 134(10 Suppl): 2752S–2759S; discussion 2765S–2767S.
5. Dimmeler S. Fleming I. Fisslthaler B. Hermann C. Busse R. Zeiher A.M. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601–605.
6. Dong K. Xu W. Yang J. Qiao H. Wu L. (2009) Neuroprotective effects of Tanshinone IIA on permanent focal cerebral ischemia in mice. Phyto ther Res 23: 608–613.
7. Dudzinski D.M. Michel T. (2007) Life history of eNOS: partners and pathways. Cardiovasc Res 75: 247–260.
8. Fulton D. Gratton J.P. McCabe T.J. Fontana J. Fujio Y. Walsh K. et al (1999) Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597–601.
9. Geng B. Cui Y. Zhao J. Yu F. Zhu Y. Xu G. et al (2007) Hydrogen sulfide downregulates the aortic L-arginine/nitric oxide pathway in rats. Am J Physiol Regul Integr Comp Physiol 293: R1608–R1618.
10. He H.B. Yang X.Z. Shi M.Q. Zeng X.W. Wu L.M. Li L.D. (2008) Comparison of cardioprotective effects of salvianolic acid B and benazepril on large myocardial infarction in rats. Pharmacol Rep 60: 369–381.
11. Ji X. Tan B.K. Zhu Y.C. Linz W. Zhu Y.Z. (2003) Comparison of cardioprotective effects using ramipril and DanShen for the treatment of acute myocardial infarction in rats. Life Sci 73: 1413–1426.
12. Ji X.Y. Tan B.K. Zhu Y.Z. (2000) Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sin 21: 1089–1094.
13. Jiang B. Zhang L. Li M. Wu W. Yang M. Wang J. et al (2008) Salvianolic acids prevent acute doxorubicin cardiotoxicity in mice through suppression of oxidative stress. Food Chem Toxicol 46: 1510–1515.
14. Kamata K. Iizuka T. Nagai M. Kasuya Y. (1993) Endothelium-dependent vasodilator effects of the extract from Salviae miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. Gen Pharmacol 24: 977–981.
15. Kang D.G. Oh H. Chung H.T. Lee H.S. (2003) Inhibition of angiotensin converting enzyme by lithospermic acid B isolated from Radix Salviae miltiorrhiza Bunge. Phyto ther Res 17: 917–920.
16. Kim D.D. Sanchez F.A. Duran R.G. Kanetaka T. Duran W.N. (2007) Endothelial nitric oxide synthase is a molecular vascular target for the Chinese herb Danshen in hypertension. Am J Physiol Heart Circ Physiol 292: H2131–H2137.
17. Kim Y.W. Lee S.M. Shin S.M. Hwang S.J. Brooks J.S. Kang H.E. et al (2009) Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury. Free Radic Biol Med 47: 1082–1092.
18. Lin H.C. Chang W.L. (2000) Diterpenoids from Salvia miltiorrhiza. Phytochemistry 53: 951–953.
19. Lutgens E. Daemen M.J. de Muinck E.D. Debets J. Leenders P. Smits J.F. (1999) Chronic myocardial infarction in the mouse: cardiac structural and functional changes. Cardiovasc Res 41: 586–593.
20. Strijdom H. Chamane N. Lochner A. (2009) Nitric oxide in the cardiovascular system: a simple molecule with complex actions. Cardiovasc J Afr 20: 303–310.
21. Takagawa J. Zhang Y. Wong M.L. Sievers R.E. Kapasi N.K. Wang Y. et al (2007) Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 102: 2104–2111.
22. Wang G. Wang L. Xiong Z.Y. Mao B. Li T.Q. (2006) Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Med Sci Monit 12: SR1–SR7.
23. Wu T.W. Zeng L.H. Fung K.P. Wu J. Pang H. Grey A.A. et al (1993) Effect of sodium tanshinone IIA sulfonate in the rabbit myocardium and on human cardiomyocytes and vascular endothelial cells. Biochem Pharmacol 46: 2327–2332.
24. Yang L.J. Jeng C.J. Kung H.N. Chang C.C. Wang A.G. Chau G.Y. et al (2005) Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J Biomed Sci 12: 347–361.
25. Zhou L. Zuo Z. Chow M.S. (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45: 1345–1359.
26. Zhou W. Ruigrok T.J. (1990) Protective effect of Danshen during myocardial ischemia and reperfusion: an isolated rat heart study. Am J Chin Med 18: 19–24.